Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis

Docetaxel (DTX) treatment effectively prolongs the overall survival of patients with prostate cancer. However, most patients eventually develop resistance to chemotherapy and experience tumor progression or even death. Long noncoding RNAs (lncRNAs) affect docetaxel chemosensitivity. However, the bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Xing, Zengshu, Li, Sailian, Xing, Jiansheng, Yu, Gang, Wang, Guoren, Liu, Zhenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162921/
https://www.ncbi.nlm.nih.gov/pubmed/35152275
http://dx.doi.org/10.1038/s41374-022-00736-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162921/
https://www.ncbi.nlm.nih.gov/pubmed/35152275
http://dx.doi.org/10.1038/s41374-022-00736-4

Ejemplares similares